Murray M. Lumpkin

Pediatric Infectious Disease

950 Devils Knob Loop
Rural Route 1, Box 568
Roseland, VA 22967

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Nearly one in five essential medicines fail quality standards in Africa: A systematic review and meta-analysis of MNCH medicines and antimalarials.

Nearly one in five essential medicines fail quality standards in Africa: A systematic review and meta-analysis of MNCH medicines and antimalarials.

Journal: PLOS global public health

Published: April 01, 2026

Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity.

Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity.

Journal: PLOS global public health

Published: December 09, 2025

Marketing Delays That Violate Global Ethical Standards-Participants but Not Patients.

Marketing Delays That Violate Global Ethical Standards-Participants but Not Patients.

Journal: JAMA internal medicine

Published: November 17, 2025

Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries.

Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries.

Journal: Journal of pharmaceutical policy and practice

Published: January 13, 2025

A roadmap for fostering timely regulatory and ethics approvals of international clinical trials in support of global health research systems.

A roadmap for fostering timely regulatory and ethics approvals of international clinical trials in support of global health research systems.

Journal: The Lancet. Global health

Published: June 25, 2024

Transparency practices at the FDA: A barrier to global health.

Transparency practices at the FDA: A barrier to global health.

Journal: Science (New York, N.Y.)

Published: August 04, 2022

Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World.

Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World.

Journal: Clinical pharmacology and therapeutics

Published: February 25, 2021

The COVID-19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics.

The COVID-19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics.

Journal: Clinical and translational science

Published: October 27, 2020

Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative.

Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative.

Journal: PLoS medicine

Published: August 14, 2020

Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.

Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.

Journal: PLoS medicine

Published: August 14, 2020

Integrating pharmaceutical systems strengthening in the current global health scenario: three 'uncomfortable truths'.

Integrating pharmaceutical systems strengthening in the current global health scenario: three 'uncomfortable truths'.

Journal: Journal of pharmaceutical policy and practice

Published: July 01, 2020

The case for an HIV cure and how to get there.

The case for an HIV cure and how to get there.

Journal: The lancet. HIV

Published: May 06, 2020

Showing 1-12 of 30

Last Updated: 09/26/2026